Stock CLNN CLENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Clene Inc.

Equities

CLNN

US1856341029

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
0.3511 USD -2.47% Intraday chart for Clene Inc. -7.63% +18.37%
06-21 Clene Says Lead Drug Candidate Shows Potential to Treat Rett Syndrome MT
06-21 Clene Inc. and Clene Nanomedicine Inc. Present Preliminary Data for CNM-Au8 as Potential Treatment for Rett Syndrome CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CLNN Stock
  4. Revisions Clene Inc.